CAM
BIIB icon

Cozad Asset Management’s Biogen BIIB Stock Holding History

Cozad Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-824
Closed -$198K – 353
2021
Q4 		$198K Sell
824
-297
-26% -$76.4K 0.03% 331
2021
Q3 		$317K Hold
1,121
– – 0.05% 266
2021
Q2 		$388K Sell
1,121
-86
-7% -$26.1K 0.06% 243
2021
Q1 		$338K Buy
1,207
+86
+8% +$23.2K 0.06% 258
2020
Q4 		$274K Sell
1,121
-89
-7% -$23K 0.05% 270
2020
Q3 		$343K Sell
1,210
-367
-23% -$102K 0.06% 235
2020
Q2 		$422K Buy
1,577
+51
+3% +$15.3K 0.09% 205
2020
Q1 		$483K Hold
1,526
– – 0.17% 131
2019
Q4 		$453K Sell
1,526
-15
-1% -$4.16K 0.12% 154
2019
Q3 		$359K Sell
1,541
-59
-4% -$13.7K 0.1% 173
2019
Q2 		$374K Sell
1,600
-815
-34% -$188K 0.11% 167
2019
Q1 		$571K Sell
2,415
-48
-2% -$15.1K 0.17% 132
2018
Q4 		$741K Buy
2,463
+237
+11% +$75.6K 0.26% 112
2018
Q3 		$786K Sell
2,226
-70
-3% -$24.1K 0.23% 111
2018
Q2 		$666K Buy
+2,296
New +$646K 0.21% 115

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Cozad Asset Management's BIIB Position: Q1 2022 in Review

Cozad Asset Management sold out of Biogen (BIIB) in Q1 2022, closing a stake of 824 shares — an estimated $198K sold.

Cozad Asset Management first reported a position in BIIB in Q2 2018 and held it in 15 quarters. The position peaked at $786K in Q3 2018. 951 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • Cozad Asset Management reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
  • Cozad Asset Management sold 824 Biogen shares in Q1 2022, an estimated $198K.
  • Cozad Asset Management first reported a position in Biogen in Q2 2018 and held it in 15 quarters.
  • Cozad Asset Management's Biogen position peaked at $786K in Q3 2018.
  • 951 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Cozad Asset Management's 13F filing for Q1 2022, filed 29 Apr 2022.